729595-78-2

Upstream product

• 15397-15-6 1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose 
• 19393-83-0 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine 
• 729595-79-3 (2R,3R,4R,5R)-2-(4-amino-6-bromo-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(benzoyloxymethyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate 

Downstream Products

• 141232-24-8 4-amino-7-(2-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile 
• 729595-88-4 C₄₀H₃₆N₆O₁₀ 
• 729595-85-1 C₃₈H₃₆N₆O₇ 
• 729595-86-2 C₃₆H₃₂N₆O₈ 
• 729595-84-0 C₃₇H₃₄N₆O₇ 
• 729595-87-3 C₃₇H₃₂N₆O₈ 
• 729595-81-7 C₃₄H₂₅ClN₄O₇ 
• 729595-80-6 C₃₄H₂₆N₄O₈ 

Relevant academic research and scientific papers

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION

The present invention describes compounds of formulae I and II and methods for treating viral infection, such as Flaviviridae virus infection, including Hepatitis C infection (HCV).

Synthesis of new 2′-β-C-methyl related triciribine analogues as anti-HCV agents

Ten new β-D-ribofuranosyl and 2′-β-C-methyl- β-D-ribofuranosyl triciribine derivatives 4-13 with various N4 and 6-N substituents on the tricyclic ring were synthesized from the corresponding toyocamycin and new 2′-β-C-methyl toyocamy